BIOTECHNOLOGY Pew Initiative on Food and Biotechnology This exploration of improved and functional foods that provide health benefits (e.g., modified fatty acids, improved proteins, modified carbohydrates) in addition to basic nutrition looks at the variety of applications as well as legal and regulatory factors for foods. See Application of Biotechnology for Functional Foods (2007) http://www.pewtrusts.org/ uploadedFiles/wwwpewtrustsorg/Reports/ Food_and_Biotechnology/PIFB_Functional_ Foods.pdf CHILDREN AND TECHNOLOGY A recent study by the British Higher Education Research Institute asked the question, how will today's children access and interact with digital resources in 10 years? A few findings: * The information literacy of young people has not improved with greater access to tech...
..., extension and teaching programs in the food and agricultural sciences to meet major needs and ...136-136y). (iv) Carry out research, technology development, technology transfer, and demonstratio... funded by the Department involving biotechnology, including the development and implementation of g...
BIOTECHNOLOGY IS SIMPLY "technology applied on biology" especially when used in agriculture, food science and medicine. Indeed, the modern world went through the physics revolution that saw the birth of nuclear power and chemical revolution that lead to the chemical and pharmaceutical industries. And now it is the biology revolution.
Exploiting scientific illiteracy THE PEW APPROACH to polling described above is reminiscent of that used by the Idaho junior high school student Nathan Zohner, who found that 8 6 percent of survey respondents thought the substance "dihydrogen monoxide" should be banned when they were told that prolonged exposure to its solid form causes severe tissue damage, exposure to its gaseous form causes severe burns, and it has been found in excised tumors of terminal cancer patients.\n It is no coincidence, according to Taverne, that eco-fundamentalists are strongly represented in anti-globalization and anti-capitalism demonstrations around the world. [...] they are strikingly simi- lar to Alexander Hamilton's summary of the reasons that the United States Constitution would not, in some quarter...
... industries that they dislike - pesticides, food additives, chemicals in general, pharmaceuticals, nuclear power, and biotechnology, among others - for opprobrium, over-regulation, a...-old antagonism toward recombinant dna technology, or gene-splicing, applied to the production of in...
The Louisiana Purchase Venture Capital Forum recently announced the Call for Business Plans in conjunction with its annual event. The call is designed to identify companies that will ultimately be selected to present at the forum, with the goal of securing investment capital. Ideal presenters will be emerging growth companies with a headquarters or significant operating presence in Louisiana. Target sectors include: biotechnology, information technology, telecommunications, environmental technology, agriculture and food technology, manufacturing and materials, industrial and energy.
...U.S. companies have led the modern biotechnology revolution in science and are spearheading the com... have greeted the arrival of the new technology. While biotechnology has aroused only limited susp...
... of current worldwide research, technology developments in Biotechnology, Bioprocessing, Bioc...
... the risks and benefits of this food technology (Hagedorn & Allender-Hagedorn, 1997; Hallman, Adel...
NEW YORK - For only the second time, the U.S. government has approved a test in people of a treatment using embryonic stem cells - this time for a rare disease that causes serious vision loss. Advanced Cell Technology, a biotechnology company based in Santa Monica., Calif., said the research should begin early next year, following the green light from the U.S. Food and Drug Administration.
Since it was founded in 1997 by Berríos and a small group of university students at La Universidad Católica in Santiago, the organization has built 42,000 homes, has recruited 200,000 volunteers and won the trust and participation of governments and multinational corporations throughout the hemisphere. Virginia Garretón, 40, a molecular biologist and CEO of Austral Biotech S.A., is at the vanguard of efforts in Chile's emerging biotechnology industry to develop technology that will help to maintain the profi tability and high quality of these products and other food commodities. Garretón and her staff of nine researchers at Austral Biotech S.A., the Santiago-based biotech research fi rm she founded in 2005 with private equity capital amounting to about $1 million, are developing cost-...
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other interesting searches:
Seven Seas Ltd | Tatiana Kovaleva | Saigon Gas Holdings Corporation | district of columbia superior court | accessory geeks | marine tidewater | conditions routières | ley proteccion mujer embarazada | codigo civil concepto | Azufre propiedades
